companydata.dkcompanydata.dk

Medbroker ApS: Financial statements 2020

CVR: 31892236

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Medbroker ApS (CVR 31892236) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 646,246 and a net result of DKK -181,611 compared with DKK 265,901 the year before. That is a decrease of 41.7% compared with the year before. Equity in the 2020 report amounted to DKK 1,636,153. The solvency ratio was 92%. The company had 1 employee in the financial year.

Gross Profit
DKK 646,246
Profit/Loss
DKK -181,611
Equity
DKK 1,636,153
Total Assets
DKK 1,778,423
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-646 t.-182 t.1.6 mio.1
2019-1.1 mio.266 t.1.8 mio.2
2018-515 t.247 t.1.6 mio.-
2017-19 t.-112 t.1.3 mio.-
2016-400 t.305 t.1.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Medbroker ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Medbroker ApS: The 2019 annual report is outJul 9, 2020

Medbroker ApS has published its annual report for 2019. Gross profit came to DKK 1,108,800, and the net result was DKK 265,901.

About Medbroker ApS

Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.

Source: annual report 2025, Danish Business Authority